申请人:Samus Therapeutics, Inc
公开号:US20210161902A1
公开(公告)日:2021-06-03
Provided herein are methods of using certain Hsp90 inhibitors in treating subjects who have experienced or are experiencing a traumatic brain injury, including lessening the short term impact of such TBI and/or reducing the risk of developing and/or the severity of long term after effects of such TBI.